Interventional cardiology at Nova Global Healthcare is led by an expert team of physicians experienced in diagnosing and treating the full range of coronary artery and peripheral vascular diseases.
Our interventional cardiologists perform procedures on patients of all ages from around the world in advanced cardiac catheterization laboratories. They lead the way in the search for better nonsurgical methods for diagnosing and treating patients with narrowed blood vessels. These methods include innovative intracoronary stent platforms, novel techniques and devices to treat completely blocked arteries, management of advanced blockages in multiple heart vessels and nonsurgical methods to treat valvular heart disease. The goals for the interventional team include improving patient outcomes, minimizing the need for open-heart surgery and helping patients who have poor survival and medical therapy options.
Ourinterventional cardiologists are engaged in leading-edge innovations, including the development and first intracoronary stent placement in New England, early development and utilization of atherectomy devices, novel gene and cell-based therapies to attempt to “grow” new heart tissue and blood vessels, and technique and technology development for the successful treatment of chronically blocked arteries.
Some of the many procedures offered at YNHH include:
Saving Times, Saving Lives
With a heart attack, time is everything. In fact your chances of survival are dramatically increased if the blockage can be treated within 90 minutes of your arrival at the hospital. Known as the door-to-balloon time (D2B), it is a performance of the time between patient entrance in the emergency department and when angioplasty is performed.
Patients admitted with chest pain have a diagnostic EKG on average within six minutes of arrival and flow restored to the heart with angioplasty and stenting of the heart artery blockage within 68 minutes, when necessary. And our advancements with EMT professionals are helping to make these times even shorter.
Our busy program and interventionalists have long been engaged in leading edge innovations, including the development and first intracoronary stent placement in New England, early development and utilization of atherectomy devices, novel gene and cell based therapies to attempt to "grow" new heart tissue and blood vessels, and technique and technology development for the successful treatment of chronically blocked arteries.
NOVA GLOBAL HEALTHCARE © 2000-2022
Content copyright 2000-2022. NOVAGLOBALHEALTHCARE.COM & NOVASUPERSPECIALITYHEALTHCARE.COM and all associated logos are registered TradeMarks of NOVA GLOBAL HEALTHCARE AND NOVA SUPER SPECIALITY HEALTHCARE.And all comapny names listen above are subsidiaries of Nova Global Healthcare having full ownership and all copyrights ONLY All rights reserved.
WEBSITE DESIGNED AND MANAGED BY NOVA GLOBAL HEALTHCARE IT DEPARTMENT
NOVA GLOBAL HEALTHCARE I NOVA SUPER SPECIALITY HEALTHCARE I NOVA MULTI SPECIALITY HEALTHCARE I NOVA GLOBAL PHARMACEUTICALS
NOVA GLOBAL DIAGNOSTIC CENTERS I NOVA GLOBAL RESEARCH CENTERS I NOVA GLOBAL NURSING INSTITUTE I NOVA GLOBAL PHARMACY